Ken Griffin Immuno Precise Antibodies Ltd. Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.98 - $1.53 $4,982 - $7,778	5,084 New	5,084 $5,000
Q4 2023 Feb 14, 2024	BUY	$1.11 - $2.3 $69,541 - $144,095	62,650 Added 506.02%	75,031 $128,000
Q3 2023 Nov 14, 2023	SELL	$1.76 - $3.04 $39,427 - $68,102	-22,402 Reduced 64.41%	12,381 $22,000
Q2 2023 Aug 14, 2023	SELL	$2.42 - $4.04 $267,969 - $447,353	-110,731 Reduced 76.1%	34,783 $102,000
Q1 2023 May 15, 2023	BUY	$2.77 - $5.49 $290,279 - $575,319	104,794 Added 257.35%	145,514 $403,000
Q4 2022 Feb 14, 2023	SELL	$4.5 - $5.72 $97,384 - $123,786	-21,641 Reduced 34.7%	40,720 $212,000
Q3 2022 Nov 14, 2022	BUY	$3.77 - $6.39 $49,760 - $84,341	13,199 Added 26.85%	62,361 $249,000

1.9M

Ticker IPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,836,700
Market Cap $10.2M
Description
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.